Relationship between serum uric acid and internal carotid resistive index in hypertensive women: A cross-sectional study

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Cipolli, José Alexandre A ^a   Ferreira Sae, Maria C ^a   Martins, Rafael P ^a   Pio Magalhães, José A ^a   Bellinazzi, Vera R ^a   Matos Souza, José R ^a   Junior, Wilson N ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Carotid artery; Gender; Intima media thickness; Resistive index; Uric acid

Indexed keywords

URIC ACID;

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL PARAMETERS; BLOOD VESSEL TONE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; INTERNAL CAROTID RESISTIVE INDEX; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; UREMIA; URIC ACID BLOOD LEVEL; YOUNG MODULUS;

BIOLOGICAL MARKERS; CAROTID ARTERY, INTERNAL; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; COMPLIANCE; CROSS-SECTIONAL STUDIES; ELASTIC MODULUS; FEMALE; HUMANS; HYPERTENSION; HYPERURICEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; URIC ACID; VASCULAR RESISTANCE; VASCULAR STIFFNESS;

EID: 84865130340     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-52     Document Type: Article

References (32)

1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821. 10.1056/NEJMra0800885, 2684330, 18946066.
2. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 2003, 41:1183-1190. 10.1161/01.HYP.0000069700.62727.C5, 12707287.
3. Viazzi F, Leoncini G, Ratto E, Pontremoli R. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived. J Clin Hypertens 2006, 8:510-518.
4. Tavil Y, Kaya MG, Oktar SO, Sen N, Okyay K, Yazici HU, Cengel A. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis 2008, 197:159-163. 10.1016/j.atherosclerosis.2007.03.008, 17416371.
5. Vlachopoulos C, Xaplanteris P, Vyssoulis G, Bratsas A, Baou K, Tzamou V, Aznaouridis K, Dima I, Lazaros G, Stefanadis C. Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension. Am J Hypertens 2011, 24:33-39. 10.1038/ajh.2010.111, 20508625.
6. Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH. Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Hear Vessel 2009, 24:371-375.
7. Cuspidi C, Valerio C, Sala C, Meani S, Esposito A, Zanchetti A, Mancia G. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am J Hypertens 2007, 20:678-685. 10.1016/j.amjhyper.2007.01.013, 17531928.
8. Tsioufis C, Kyvelou S, Dimitriadis K, Syrseloudis D, Sideris S, Skiadas I, Katsi V, Stefanadi E, Lalos S, Mihas C, Poulakis M, Stefanadis C. The diverse associations of uric acid with low-grade inflammation, adiponectin and arterial stiffness in never-treated hypertensives. J Hum Hypertens 2011, 25:554-559. 10.1038/jhh.2010.98, 20962858.
9. Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchiger B. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 2006, 37:800-805. 10.1161/01.STR.0000202589.47401.c6, 16439703.
10. Berni A, Boddi M, Fattori EB, Cecioni I, Berardino S, Montuschi F, Chiostri M, Poggesi L. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers. Am J Hypertens 2010, 23:675-680. 10.1038/ajh.2010.33, 20203626.
11. Viazzi F, Leoncini G, Ratto E, Falqui V, Parodi A, Conti N, Derchi LE, Tomolillo C, Deferrari G, Pontremoli R. Mild hyperuricemia and subclinical renal damage in untreated primary hypertension. Am J Hypertens 2007, 20:1276-1282. 10.1016/j.amjhyper.2007.08.010, 18047917.
12. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B, . LIFE Study Group The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004, 65:1041-1049. 10.1111/j.1523-1755.2004.00484.x, 14871425, LIFE Study Group.
13. Heo SH, Lee SH. High levels of serum uric acid are associated with silent brain infarction. J Neurol Sci 2010, 297:6-10. 10.1016/j.jns.2010.07.007, 20674933.
14. Pio-Magalhães JA, Cornélio M, Leme CA, Matos-Souza JR, Garlipp CR, Gallani MC, Rodrigues RC, Franchini KG, Nadruz W. Upper arm circumference is an independent predictor of left ventricular concentric hypertrophy in hypertensive women. Hypertens Res 2008, 31:1177-1183. 10.1291/hypres.31.1177, 18716366.
15. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011, 63:3136-3141. 10.1002/art.30520, 21800283.
16. Summary E. The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702.
17. Cipolli JA, Souza FA, Ferreira-Sae MC, Pio-Magalhães JA, Figueiredo ES, Vidotti VG, Matos-Souza JR, Franchini KG, Nadruz W. Sex-specific hemodynamic and non-hemodynamic determinants of aortic root size in hypertensive subjects with left ventricular hypertrophy. Hypertens Res 2009, 32:956-961. 10.1038/hr.2009.134, 19713970.
18. Ferreira-Sae MC, Cipolli JA, Cornélio ME, Matos-Souza JR, Fernandes MN, Schreiber R, Costa FO, Franchini KG, Rodrigues RC, Gallani MC, Nadruz W. Sodium intake is associated with carotid artery structure alterations and plasma matrix metalloproteinase-9 upregulation in hypertensive adults. J Nutr 2011, 141:877-882. 10.3945/jn.110.135921, 21430243.
19. Hernesniemi JA, Raitakari OT, Kähönen M, Juonala M, Hutri-Kähönen N, Marniemi J, Viikari J, Lehtimäki T. Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study. Atherosclerosis 2008, 198:152-159. 10.1016/j.atherosclerosis.2007.09.024, 17996871.
20. Gemignani T, Matos-Souza JR, Coelho OR, Franchini KG, Nadruz W. Postural changes may influence popliteal atherosclerosis by modifying local circumferential wall tension. Hypertens Res 2008, 31:2059-2064. 10.1291/hypres.31.2059, 19098378.
21. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on the blood pressure of adolescents with newly diagnosed essential hypertension. JAMA 2008, 300:924-932. 10.1001/jama.300.8.924, 2684336, 18728266.
22. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002, 106:221-226. 10.1161/01.CIR.0000022140.61460.1D, 12105162.
23. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006, 47:51-59. 10.1053/j.ajkd.2005.10.006, 16377385.
24. Lee MY, Wu CM, Chu CS, Lee KT, Sheu SH, Lai WT. Association of carotid hemodynamics with risk of coronary heart disease in a Taiwanese population with essential hypertension. Am J Hypertens 2008, 21:696-700. 10.1038/ajh.2008.160, 18437128.
25. Frauchiger B, Schmid HP, Roedel C, Moosmann P, Staub D. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 2001, 32:836-841. 10.1161/01.STR.32.4.836, 11283379.
26. Culleton BF. Uric acid and cardiovascular disease: a renal-cardiac relationship?. Curr Opin Nephrol Hypertens 2001, 10:371-375. 10.1097/00041552-200105000-00012, 11342800.
27. Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women-the Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2008, 10:R116. 10.1186/ar2519, 2592803, 18822120.
28. Paini A, Boutouyrie P, Calvet D, Tropeano AI, Laloux B, Laurent S. Carotid and aortic stiffness: determinants of discrepancies. Hypertension 2006, 47:371-376. 10.1161/01.HYP.0000202052.25238.68, 16446398.
29. Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol 2012, 11:2. 10.1186/1475-2840-11-2, 3293733, 22234039.
30. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005, 25:1038-1044. 10.1161/01.ATV.0000161274.87407.26, 15746438.
31. Sica DA, Carter B, Cushman W, Hamm L. Thiazide and loop diuretics. J Clin Hypertens 2011, 13:639-643.
32. Würzner G, Gerster JC, Chiolero A, Maillard M, Fallab-Stubi CL, Brunner HR, Burnier M. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout. J Hypertens 2001, 19:1855-1860. 10.1097/00004872-200110000-00021, 11593107.